Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
Abstract Introduction This article aims to describe malignancies in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), or non-radiographic axial spondyloarthritis (nr-axSpA) treated with upadacitinib (UPA) or active comparators. Methods This integrated s...
| المؤلفون الرئيسيون: | , , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Adis, Springer Healthcare
2023-11-01
|
| سلاسل: | Rheumatology and Therapy |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1007/s40744-023-00621-6 |